Pharming Group NV (PHAR)
9.68
-0.12
(-1.22%)
USD |
NASDAQ |
Oct 06, 16:00
Pharming Group Market Cap : 685.13M for Oct. 6, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 06, 2026 | 685.13M |
| October 05, 2026 | 693.63M |
| October 02, 2026 | 690.09M |
| October 01, 2026 | 704.24M |
| September 30, 2026 | 707.07M |
| September 29, 2026 | 708.49M |
| September 28, 2026 | 744.59M |
| September 25, 2026 | 740.34M |
| September 24, 2026 | 738.92M |
| September 23, 2026 | 762.28M |
| September 22, 2026 | 796.96M |
| September 21, 2026 | 765.11M |
| September 18, 2026 | 746.71M |
| September 17, 2026 | 762.99M |
| September 16, 2026 | 750.25M |
| September 15, 2026 | 746.71M |
| September 14, 2026 | 765.82M |
| September 11, 2026 | 793.42M |
| September 10, 2026 | 764.76M |
| September 09, 2026 | 776.44M |
| September 08, 2026 | 813.95M |
| September 04, 2026 | 794.84M |
| September 03, 2026 | 811.12M |
| September 02, 2026 | 792.71M |
| September 01, 2026 | 786.34M |
| Date | Value |
|---|---|
| August 31, 2026 | 812.53M |
| August 28, 2026 | 828.10M |
| August 27, 2026 | 833.77M |
| August 26, 2026 | 845.80M |
| August 25, 2026 | 833.06M |
| August 24, 2026 | 811.12M |
| August 21, 2026 | 838.72M |
| August 20, 2026 | 826.69M |
| August 19, 2026 | 838.72M |
| August 18, 2026 | 842.97M |
| August 17, 2026 | 834.47M |
| August 14, 2026 | 829.52M |
| August 13, 2026 | 874.11M |
| August 12, 2026 | 837.30M |
| August 11, 2026 | 865.62M |
| August 10, 2026 | 803.33M |
| August 07, 2026 | 775.02M |
| August 06, 2026 | 767.94M |
| August 05, 2026 | 755.56M |
| August 04, 2026 | 726.18M |
| August 03, 2026 | 695.04M |
| July 31, 2026 | 713.44M |
| July 30, 2026 | 760.86M |
| July 29, 2026 | 850.04M |
| July 28, 2026 | 910.21M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| ProQR Therapeutics NV | 229.32M |
| NewAmsterdam Pharma Co. NV | 2.659B |
| argenx SE | 58.01B |
| Nektar Therapeutics | 1.346B |
| ACADIA Pharmaceuticals, Inc. | 3.386B |
Market Cap Related Metrics
| PE Ratio | 77.88 |
| PS Ratio | 1.946 |
| Price to Book Value | 2.666 |
| Price to Free Cash Flow | 27.73 |
| Price | 9.68 |
| Earnings Yield | 1.28% |
| Operating PE Ratio | 31.88 |
| Normalized PE Ratio | 43.45 |